A detailed history of Toroso Investments, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Toroso Investments, LLC holds 12,592 shares of EXAS stock, worth $830,568. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,592
Previous 8,257 52.5%
Holding current value
$830,568
Previous $570,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $179,165 - $321,917
4,335 Added 52.5%
12,592 $532,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $464,621 - $609,118
8,257 New
8,257 $570,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $77,159 - $117,006
-1,231 Reduced 18.32%
5,490 $515,000
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $317,163 - $475,645
6,721 New
6,721 $456,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $61,890 - $132,487
1,738 New
1,738 $68,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.